TY - JOUR AU - Sundaresan, N. AU - Rosen, G. AU - Boriani, S. PY - 2009 DA - 2009// TI - Primary malignant tumors of the spine JO - Orthop Clin North Am VL - 40 UR - https://doi.org/10.1016/j.ocl.2008.10.004 DO - 10.1016/j.ocl.2008.10.004 ID - Sundaresan2009 ER - TY - CHAP AU - Mascarenhas, L. AU - Siegel, S. AU - Spector, L. AU - Arndt, C. AU - Femino, D. AU - Malogolowkin, M. ED - Bleyer, A. ED - O’Leary, M. ED - Barr, R. PY - 2006 DA - 2006// TI - Malignant bone tumors BT - Cancer epidemiology in older adolescents and young adults 15 to 29 years of age, including SEER incidence and survival: 1975–2000 PB - National Cancer Institute CY - Bethesda, MD ID - Mascarenhas2006 ER - TY - JOUR AU - Applebaum, M. A. AU - Worch, J. AU - Matthay, K. K. AU - Goldsby, R. AU - Neuhaus, J. AU - West, D. C. AU - DuBois, S. G. PY - 2001 DA - 2001// TI - Clinical features and outcomes in patients with extraskeletal Ewing sarcoma JO - Cancer. VL - 117 UR - https://doi.org/10.1002/cncr.25840 DO - 10.1002/cncr.25840 ID - Applebaum2001 ER - TY - JOUR AU - Cotterill, S. J. AU - Ahrens, S. AU - Paulussen, M. AU - Jurgens, H. F. AU - Voute, P. A. AU - Gadner, O. H. AU - Craft, A. W. PY - 2000 DA - 2000// TI - Prognostic factors in Ewing‘s tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing’s Sarcoma Study Group JO - J Clin Oncol. VL - 18 UR - https://doi.org/10.1200/JCO.2000.18.17.3108 DO - 10.1200/JCO.2000.18.17.3108 ID - Cotterill2000 ER - TY - JOUR AU - Arpaci, E. AU - Yetisyigit, T. AU - Seker, M. AU - Uncu, D. AU - Uyeturk, U. AU - Oksuzoglu, B. AU - Demirci, U. AU - Coskun, U. AU - Kucukoner, M. AU - Isukdogan, A. AU - Inanc, M. AU - Alkis, N. AU - Ozkan, M. PY - 2013 DA - 2013// TI - Prognostic factors and clinical outcome of patients with Ewing’s sarcoma family of tumors in adults: multicentric study of the Anatolian Society of Medical Oncology JO - Med Oncol VL - 30 UR - https://doi.org/10.1007/s12032-013-0469-z DO - 10.1007/s12032-013-0469-z ID - Arpaci2013 ER - TY - JOUR AU - Gaspar, N. AU - Rey, A. PY - 2012 DA - 2012// TI - Be´rard PM, Michon J, Gentet JC, Tabone MD. Risk adapted chemotherapy for localised Ewing’s sarcoma of bone: the French EW93 study JO - Eur J Cancer VL - 48 UR - https://doi.org/10.1016/j.ejca.2012.03.017 DO - 10.1016/j.ejca.2012.03.017 ID - Gaspar2012 ER - TY - JOUR AU - Guerra, J. L. L. AU - Márquez-Vega, C. AU - Ramírez-Villar, G. L. AU - Cabrera, P. AU - Ordóñez, R. AU - Praena-Fernández, J. M. AU - Ortiz, M. J. PY - 2012 DA - 2012// TI - Prognostic factors for overall survival in paediatric patients with Ewing sarcoma of bone treated according to multidisciplinary protocol JO - Clin Transl Oncol VL - 14 UR - https://doi.org/10.1007/s12094-012-0798-y DO - 10.1007/s12094-012-0798-y ID - Guerra2012 ER - TY - JOUR AU - Krakorova, D. A. AU - Kubackova, K. AU - Dusek, L. AU - Tomas, T. AU - Janicek, P. AU - Tucek, S. AU - Prausova, J. AU - Kiss, I. AU - Zambo, I. PY - 2018 DA - 2018// TI - Advantages in prognosis of adult patients with Ewing sarcoma: 11-years experiences and current treatment management JO - Pathol Oncol Res. VL - 24 UR - https://doi.org/10.1007/s12253-017-0291-6 DO - 10.1007/s12253-017-0291-6 ID - Krakorova2018 ER - TY - JOUR AU - Pan, H. Y. AU - Morani, A. AU - Wang, W. L. AU - Hess, K. R. AU - Paulino, A. C. AU - Ludwig, J. A. AU - Lin, P. P. AU - Daw, N. C. AU - Mahajan, A. PY - 2015 DA - 2015// TI - Prognostic factors and patterns of relapse in Ewing sarcoma patients treated with chemotherapy and r0 resection JO - Int J Radiat Oncol Biol Phys VL - 92 UR - https://doi.org/10.1016/j.ijrobp.2015.01.022 DO - 10.1016/j.ijrobp.2015.01.022 ID - Pan2015 ER - TY - JOUR AU - Arshi, A. AU - Sharim, J. AU - Park, D. Y. AU - Park, H. Y. AU - Yazdanshenas, H. AU - Bernthal, N. M. AU - Shamie, A. N. PY - 2016 DA - 2016// TI - Prognostic determinants and treatment outcomes analysis of osteosarcoma and Ewing sarcoma of the spine JO - Spine J VL - 17 UR - https://doi.org/10.1016/j.spinee.2016.11.002 DO - 10.1016/j.spinee.2016.11.002 ID - Arshi2016 ER - TY - JOUR AU - Biswas, B. AU - Thakar, A. AU - Mohanti, B. K. AU - Vishnubhatla, S. AU - Bakhshi, S. PY - 2015 DA - 2015// TI - Prognostic factors in head and neck Ewing sarcoma family of tumors JO - Laryngoscope VL - 125 UR - https://doi.org/10.1002/lary.24985 DO - 10.1002/lary.24985 ID - Biswas2015 ER - TY - JOUR AU - Miller, B. J. AU - Lynch, C. F. AU - Buckwalter, J. A. PY - 2013 DA - 2013// TI - Conditional survival is greater than overall survival at diagnosis in patients with osteosarcoma and Ewing’s sarcoma JO - Clin Orthop Relat Res VL - 471 UR - https://doi.org/10.1007/s11999-013-3147-8 DO - 10.1007/s11999-013-3147-8 ID - Miller2013 ER - TY - STD TI - Harrel FJ. rms: regression modeling strategies. R package version 5.0-0. http://CRAN.R-project.org/package=rms. Accessed March 3, 2017. UR - http://cran.r-project.org/package=rms ID - ref13 ER - TY - STD TI - Gray B. cmprsk: subdistribution analysis of competing risks. R package version 2.2-7. http://CRAN.R-project.org/package=cmprsk. Accessed March 3, 2017. UR - http://cran.r-project.org/package=cmprsk ID - ref14 ER - TY - JOUR AU - Grünewald, T. G. AU - Cidre-Aranaz, F. AU - Surdez, D. AU - Tomazou, E. M. AU - Álava, E. AU - Kova, H. AU - Sorensen, P. H. AU - Dilattre, O. AU - Dirksen, U. PY - 2018 DA - 2018// TI - Ewing sarcoma JO - Nat Rev Dis Primers. VL - 4 UR - https://doi.org/10.1038/s41572-018-0003-x DO - 10.1038/s41572-018-0003-x ID - Grünewald2018 ER - TY - JOUR AU - Balachandran, V. P. AU - Gonen, M. AU - Smith, J. J. AU - DeMatteo, R. P. PY - 2015 DA - 2015// TI - Nomograms in oncology: more than meets the eye JO - Lancet Oncol. VL - 16 UR - https://doi.org/10.1016/S1470-2045(14)71116-7 DO - 10.1016/S1470-2045(14)71116-7 ID - Balachandran2015 ER - TY - JOUR AU - Cash, T. AU - McIlvaine, E. AU - Krailo, M. D. AU - Lessnick, S. L. AU - Lawlor, E. R. AU - Laack, N. AU - Womer, R. B. PY - 2016 DA - 2016// TI - Comparison of clinical features and outcomes in patients with extraskeletal versus skeletal localized Ewing sarcoma: a report from the Children's Oncology Group JO - Pediatr Blood Cancer. VL - 63 UR - https://doi.org/10.1002/pbc.26096 DO - 10.1002/pbc.26096 ID - Cash2016 ER - TY - JOUR AU - Esiashvili, N. AU - Goodman, M. AU - Marcus, R. B. PY - 2008 DA - 2008// TI - Changes in incidence and survival of Ewing sarcoma patients over the past 3 decades: surveillance epidemiology and end results data JO - J Pediatr Hematol Oncol. VL - 30 UR - https://doi.org/10.1097/MPH.0b013e31816e22f3 DO - 10.1097/MPH.0b013e31816e22f3 ID - Esiashvili2008 ER - TY - JOUR AU - Bernstein, M. L. AU - Devidas, M. AU - Lafreniere, D. AU - Souid, A. K. AU - Meyers, P. A. AU - Gebhardt, M. AU - Perlman, E. J. AU - Dubowy, R. AU - Stein, K. AU - Nicholas, R. AU - Wainer, I. W. AU - Dickman, P. S. AU - Link, M. P. AU - Goorin, A. AU - Grier, H. E. PY - 2006 DA - 2006// TI - Intensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis: pediatric oncology group/children’s cancer group phase II study 9457—a report from the Children’s oncology group JO - J Clin Oncol VL - 24 UR - https://doi.org/10.1200/JCO.2005.02.1717 DO - 10.1200/JCO.2005.02.1717 ID - Bernstein2006 ER - TY - JOUR AU - Alava, E. PY - 2017 DA - 2017// TI - Ewing Sarcoma, an update on molecular pathology with therapeutic implications JO - Surg Pathol Clin. VL - 10 UR - https://doi.org/10.1016/j.path.2017.04.001 DO - 10.1016/j.path.2017.04.001 ID - Alava2017 ER - TY - STD TI - Renzi S, Anderson ND, Light N, Gupta A. Ewing-like sarcoma: an emerging family of round cell sarcomas. J Cell Physiol. 2018. ID - ref21 ER - TY - JOUR AU - Sannino, G. AU - Orth, M. F. AU - Grünewald, T. G. PY - 2017 DA - 2017// TI - Next steps in Ewing sarcoma (epi-)genomics JO - Future Oncol. VL - 13 UR - https://doi.org/10.2217/fon-2017-0159 DO - 10.2217/fon-2017-0159 ID - Sannino2017 ER - TY - JOUR AU - Pretz, J. L. AU - Barysauskas, C. M. AU - George, S. AU - Hornick, J. L. AU - Raut, C. P. AU - Chen, Y. L. E. AU - DeLaney, T. F. PY - 2017 DA - 2017// TI - Localized adult Ewing sarcoma: favorable outcomes with alternating vincristine, doxorubicin, cyclophosphamide, and ifosfamide, etoposide (VDC/IE)-based multimodality therapy JO - Oncologist. VL - 22 UR - https://doi.org/10.1634/theoncologist.2016-0463 DO - 10.1634/theoncologist.2016-0463 ID - Pretz2017 ER -